CYREN (CYRN) Reports Q2 Loss of $0.04/Share
Tweet
Share
E-mailGet Alerts CYRN Hot Sheet
Join SI Premium – FREE
CYREN (NASDAQ: CYRN) reported Q2 EPS of ($0.04), versus ($0.04) reported last year. Revenue for the quarter came in at $6.7 million, versus $8.3 million reported last year.
For earnings history and earnings-related data on CYREN (CYRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
- Traws Pharma (TRAW) Tops Q2 EPS by 27c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
